B06AC05 lanadelumab
ATC group of level 5 – chemical substance · in plain English: other medicines for the blood
This site has the patient leaflet or the SPC of 4 medicines in this group.
- 4 prescription only (POM)
Active substance: Lanadelumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B06 Other hematological agents 24 medicines
- B06A Other hematological agents 24 medicines
- B06AC Drugs used in hereditary angioedema 20 medicines
- B06AC05 lanadelumab 4 medicines
- B06AC Drugs used in hereditary angioedema 20 medicines
- B06A Other hematological agents 24 medicines
- B06 Other hematological agents 24 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Takhzyro SPC | Prescription only (POM) |
| Takhzyro 150 mg solution for injection in Pre-filled syringe | Prescription only (POM) |
| Takhzyro 300 mg solution for injection SPC | Prescription only (POM) |
| Takhzyro 300 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
Other groups of the same level
- B06AC01 c1-inhibitor, plasma derived 6 medicines
- B06AC02 icatibant 6 medicines
- B06AC04 conestat alfa 3 medicines
Other names of the ATC group
- German: B06AC05 Lanadelumab
- Spanish: B06AC05 LANADELUMAB
- German: B06AC05 Lanadelumab
- Italian: B06AC05 LANADELUMAB
- Turkish: B06AC05 lanadelumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B06AC05
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.